Epidemiological characteristics and morbidity of Snake-bites in Zunyi city, China

Abstract

Objectives: To investigate the epidemiological characteristics and morbidity of the snake-bite injury in Zunyi city, China, so as to provide the first aid guidance and public education for the prevention and treatment strategies of snake-bite injuries.

Methods: A cross-sectional study was conducted, and 548 cases of snake-bite were observed in this study between January 1, 2015 to December 31, 2017. They were identified form the Emergency Department of the Affiliated Hospital of Zunyi Medical University. A retrospective epidemiological survey was conducted to collect their information on sex, age, occupation, bite location, bite year and season, specific bite cause.

Results: The number of the patients of snake-bite was increased; however, the fatality rate gradually was decreased year by year during the investigating period. Seven patients died during year 2015-2017 and the 3-year total mortality was 2.9%. Among the dead, 59.31% were male and 40.69% were female. 19.70% of patients were between 41 and 50 years old, 17.70% were between 51 and 60 years and 16.79% of patients were between 61 and 70 years old. Moreover, 66.97% of patients were on the lower extremity and 31.93% of patients on the upper extremity. 83.39% of patients were bitten while farming and 12.04% of patients were bitten while walking. Most cases occurred during summer and autumn (7-9 months) seasons. The regional distributions of 548 snake-bites were 44.34% in the County and 33.94% in districts of Zunyi city.

Conclusion: Target preventive measures should be conducted in high risk populations in Zunyi city, especially in spring and summer.

Keywords

Snake / Snake-bite / Epidemiology Distribution / Zunyi

References

[1] Warrell DA. Snake bite. Lancet 2010; 375: 77-88. https://doi.org/10.1016/S0140-6736(09)61754-2

[2] Alirol E, Sharma SK, Bawaskar HS. Snake bite in South Asia: A review. PLoS Negl Trop Dis. 2010; 4(e603): 1-9. PMid:20126271. https://doi.org/10.1371/journal.pntd.0000603

[3] Ratanabanangkoon K, Tan KY, Eursakun S. A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia. PLoS Negl Trop Dis. 2016; 10(e0004565): 1-20. PMid:27058956. https://doi.org/10.1371/journal.pntd.0004565

[4] Snake bite-the neglected tropical disease. The Lancet. 2015; 386(9999): 1110-1110. https://doi.org/10.1016/S0140-6736(15)00247-0

[5] Wang W, Chen QF, Yin X. Clinical features and treatment experience: A review of 292 Chinese cobra snakebites. Environ Toxicol Pharmacol. 2014; 37: 648-655. PMid:24577231. https://doi.org/10.1016/j.etap.2013.12.018

[6] Ozkol HU, Karadag AS, Bilgili SG. A patient with snakebite presenting with thrombophlebitis-like appearance and DIC. Cutan Ocul Toxicol. 2011; 30: 312-314. PMid:21517720. https://doi.org/10.3109/15569527.2011.573832

[7] Kanaan NC, Ray J, Stewart M. Wilderness Medical Society Practice Guidelines for the Treatment of Pitviper Envenomation in the United States and Canada. Wilderness Environ Med. 2015; 26: 472-487. PMid:26433731 https://doi.org/10.1016/j.wem.2015.05.007

[8] Joslin JD, Marraffa JM, Singh H. Incidence and Characteristics of Snakebite Envenomations in the New York State between 2000 and 2010. Wilderness Environ Med. 2014; 25: 289-294. PMid:24841342. https://doi.org/10.1016/j.wem.2014.01.017

[9] Wasko DK, Bullard SG. An Analysis of Media-Reported Venomous Snakebites in the United States, 2011-2013. Wilderness Environ Med. 2016; 27: 219-226. PMid:27161436. https://doi.org/10.1016/j.wem.2016.01.004

[10] Spyres MB, Ruha AM, Seifert S. Occupational Snake Bites: a Prospective Case Series of Patients Reported to the ToxIC North American Snakebite Registry. J Med Toxicol. 2016; 12: 365-369. PMid:27234295. https://doi.org/10.1007/s13181-016-0555-7

[11] Singh J, Bhoi S, Gupta V. Clinical profile of venomous snake bites in north Indian Military Hospital. J Emerg. Trauma Shock. 2008; 1: 78-80. PMid:19561985. https://doi.org/10.4103/0974-2700.43184

[12] Haviv J, Huerta M, Shpilberg O. Field treatment of snakebites in the Israel Defense Forces. Public Health Rev. 1998; 26: 247-256.

[13] ZHAO XD, Zhang JB. The treatment of Agkistrodon Halys bite injury in Noah China. Chinese Journal of Critical Care Medicine. 2015; 35(1): 91-94.

[14] Lin CC, Chaou CH, Tseng CY. An investigation of snakebite antivenom usage in Taiwan. J Formos Med Assoc. 2016; 115: 672-677. PMid:26250942. https://doi.org/10.1016/j.jfma.2015.07.006

[15] Chen CK, Lin CC, Shih FY. Population-based study of venomous snakebite in Taiwan. J Acute Med. 2015; 5: https://doi.org/10.1016/j.jacme.2015.04.004

[16] Fung HT, Lam SK, Lam KK. A survey of snakebite management knowledge amongst select physicians in Hong Kong and the implications for snakebite training. Wilderness Environ Med. 2009; 20: 364-370. PMid:20030446. https://doi.org/10.1580/1080-6032-020.004.0364

[17] Shuang J, Chen Y, Ran Q. A ten-year retrospective review of 1107 snakebite patients in Sanya, China. Chin Med J. 2014; 127: 2189-2191.

[18] Cai HY, He YJ, Xiao X. Epidemic analysis of the acute snakebite around Guizhou Zunyi area. Journal of Clinical Emergency. 2013; 8: 369-370.

[19] Duan HZ, Song RJ, Zhang XJ. Clinical characteristics of 428 human bites. Chongqing Medicine. 2019; (5): 131-133.

[20] Chulin C, Li G, Ting K. A Survey of Snakebite Knowledge among Field Forces in China. International Journal of Environmental Research and Public Health. 2017; 14(15): 1-10. PMid:28035960 https://doi.org/10.3390/ijerph14010015

[21] Guidelines for the Management of Snake-Bites. Available from: http://apps.searo.who.int/PDS_DOCS/B4508.pdf?ua=1 (accessed on 20 August 2016)